Cardioprotection mediated by exosomes is impaired in the setting of type II diabetes but can be rescued by the use of non‐diabetic exosomes in vitro

Many patients with ischaemic heart disease also have diabetes. As myocardial infarction is a major cause of mortality and morbidity in these patients, treatments that increase cell survival in response to ischaemia and reperfusion are needed. Exosomes—nano‐sized, lipid vesicles released from cells—c...

Descripción completa

Detalles Bibliográficos
Autores principales: Davidson, Sean M., Riquelme, Jaime A., Takov, Kaloyan, Vicencio, Jose M., Boi‐Doku, Claire, Khoo, Vanessa, Doreth, Christian, Radenkovic, Dina, Lavandero, Sergio, Yellon, Derek M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742744/
https://www.ncbi.nlm.nih.gov/pubmed/28840975
http://dx.doi.org/10.1111/jcmm.13302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742744/
https://www.ncbi.nlm.nih.gov/pubmed/28840975
http://dx.doi.org/10.1111/jcmm.13302

Ejemplares similares